Diabetes

Develop more effective treatment & prevention strategies

Bioelectrical Impedance Analysis device that is ARTG Registered.
Australian Register of Therapeutic Goods (ARTG) #207297

Why is body composition analysis an effective tool for diabetes programs?

Studies have proved InBody DSM-BIA body composition analysers are an effective tool for monitoring patients’ diabetic risks and symptoms. InBody products do not rely on empirical data, therefore, medical professionals can be certain the outputs generated by the device precisely reflect changes happening in the patient.

Disclaimer: InBody devices should be used as an adjunct tool for clinical decision making and are not intended to diagnose or treat any diseases.

Obtain objective measurements of muscle, fat, and visceral fat to assess health risks

Monitor outcomes of interventions aimed to improve glycemic control and prevent worsening of complications related to diabetes

Detect fluid imbalances resulting from inflammation

Visceral Fat Analysis

Understand severity of diabetes risk

Current methods of estimating visceral fat measures are indirect and imprecise, making them a poor tool for overall health risk assessments and long-term tracking. InBody provides a visceral fat measurement, this is a known link to increased risk of hypertension, high cholesterol, and diabetes.

Waist circumference measurements serve as an indirect indicator of overall and visceral obesity; however, this method is imprecise and inadequate for monitoring changes over time. By using InBody to assess body composition, medical professionals can rely on precise and consistent measurements to monitor their patient’s risk for diabetes and/or other health conditions. As InBody’s visceral fat area is closely linked to diabetic risk, outputs including the Edema Index (ECW/TBW ratio) are also useful for tracking diabetes-related inflammation. This data will provide diabetes professionals with a better indicator for which factors may be causing health risks and set better prescriptions for change.

Muscle-Fat & Segmental Lean Analysis

Monitor muscle & fat distribution

Diabetic risk increase is driven by both excess fat mass and low muscle mass, however, body composition methods for diabetic risk are inaccurate or inconsistent. Quantification of muscle and fat mass by region provides a more in-depth view of segmental and overall body composition and allows for better analysis of diabetes risk and guidance of treatment options.

Diabetes is often associated with excess fat, however having insufficient muscle mass is just as detrimental and increases diabetes risk. Leg muscles are the largest muscle group in the body and therefore serve as a driver for glucose uptake; low leg muscle mass is associated with increased risk of insulin resistance.

With InBody, medical professionals can assess and monitor a patient’s composition of muscle and fat. Outputs such Segmental Lean Mass and Leg Lean Mass provide deeper insight into the composition of leg muscle as well as the storage of fat across the body. By monitoring these factors and setting specific treatment programs to address the patient’s unique physiology, physicians and educators can track the progress and success of treatments and interventions.

Segmental ECW/TBW Water Analysis

Monitor fluid accumulation in each body segment

Systemic inflammation caused by excess visceral fat and inflammatory hormones increase fluid retention and a patient’s risk for developing comorbidities, such as cardiovascular and renal disease. Direct and objective measures of body water can increase detection of water retention and reduce risk of secondary health conditions linked to diabetes.

By using InBody, medical professionals can track whole body ECW/TBW, a marker of inflammation and fluid imbalance, through the direct measurement of extracellular and total body water. Monitoring the Edema Index (ECW/TBW) provides an assessment of fluid accumulation in the extracellular space resulting from compromised cardiovascular function.

These measures are provided for the whole body as well as ratios specific to each segment of the arms, legs, and trunk to identify where fluid imbalances may be occurring allowing for more precise analysis and earlier indication of truncal or leg edema, aiding cardiology professionals to develop more effective fluid management strategies to improve patient outcomes.

Body Composition History

Track changes in muscle, fat & fluid balance to chart progress

The best way to prevent or reverse diabetes is by making healthy-focused behavioural and lifestyle changes. However, health professionals often have a hard time keeping patients engaged in a diet and exercise regimen. With a comprehensive body composition report, InBody devices show patients the changes that ordinary weight scales are incapable of showing and provide an educational outline to start a discussion towards lifestyle change. In addition, patients and providers can use the Body Composition History section to chart their progress throughout interventions and make adjustments to optimise results and health outcomes.

Skeletal Muscle Index

Identify frailty risk & sarcopenia

Diabetics patients tend to lose muscle mass. This loss in muscle mass tends to increase with the duration of diabetes, thus leading to the development of other conditions, including sarcopenia. InBody provides a skeletal muscle index (SMI) output that allows for the monitoring of skeletal muscle mass to help prevent or identify sarcopenia. It is well known that skeletal muscle mass is important to monitor for diabetics. This results from glucose not being utilised to assist in building muscle as well as decreased physical activity causing muscle mass to deplete. This can also cause increased fatigue and further reduction of physical activity and function. The resulting decrease in muscle mass experienced by these patients increases the risk for other conditions such as sarcopenia and impaired mobility. Sarcopenia is the loss of skeletal muscle mass, which decreases functional mobility and quality of life and increases risk of hospitalisation and mortality. Sarcopenia is often associated with ageing; however, it can occur in a variety of populations due to sedentary behaviour or even disease. The SMI is used in order to assess and conveniently monitor skeletal muscle mass to aid in the diagnosis of sarcopenia. SMI is calculated as the sum of appendicular lean mass, normalised to height. With the prevalence of muscle loss in diabetics and the association diabetes and sarcopenia, monitoring risk for sarcopenia in diabetics is imperative. Using the SMI output on InBody results will allow medical professionals to identify the risk of sarcopenia in easily identify increased frailty risk and promote education and intervention.

Why do allied health professionals trust InBody?

Biometric data is gathered by InBody’s four core technologies to deliver quick, non-invasive and precise results. These technologies allow you to trust that the results reflect your patients’ true health from the inside out.

Multiple frequencies

InBody uses multiple frequencies to provide a precise analysis.

By using several different frequencies, more resistance values are attained, providing more information during the analysis. The InBody 970 uses 8 frequencies to measure each segment of the body, providing a total of 30 separate impedance values.

Electrical currents have a different penetration force depending on the frequency. Low frequencies measure the water outside the cell (extracellular water), as they are unable to penetrate the cell wall. Higher frequencies will measure the water content inside the cell (intracellular water) because it penetrates the cell wall.

By using a diverse set of frequencies, the InBody can measure water contents inside and outside the cell separately. Controlling the path of high frequency waves is very difficult. This technical know-how is an InBody specific specialty and has been accumulated over many years of experience in the field.

8-Point Tactile Electrode System

When measuring impedance through any type of electrode, contact resistance occurs. It is important to control the contact resistance, in order to correctly measure the resistance in the body.

The 8-point tactile method separates the current and voltage starting point. This measurement always begins at a fixed point in the wrists and ankles. This is advantageous, as the contact resistance from the skin has been removed. This creates the high precision of reproducing the results that InBody are renowned for.

Measuring the body parts individually

The technical term for this is Direct Segmental Multi-frequency Bioelectrical Impedance Analysis (DSM-BIA). It separately measures the impedance (resistance to alternating electric currents) of the trunk, arms, and legs of our body.

This new measurement concept measures the resistance of the cross point of two flows and takes the resistance values of the arms, legs and the body trunk.

Why is this important? The human body is composed of five cylinders: the arms, legs and trunk. With the technology of the InBody, the trunk is directly measured. The trunk is occupied by various internal organs and its metabolic characteristics are different from the other parts of the body. Although difficult, it is important to precisely and directly measure the trunk, since the trunk has very low resistance compared to the arms and legs.

No Statistical Data Needed

InBody is the only BIA device that measures body composition without relying on age and gender to make assumptions about your measurement. The results are extremely precise, and as unique as the person standing on the device.

InBody provides individualised result for better tracking of progress to help you achieve your goals. You can change your age and/or gender on an InBody device and your measurement will not change because you have not changed.

This is one of the underpinning reasons why InBody is used around the world in extensive studies and utilised by top sports people, medical institutions and NASA.

Trusted By Medical Experts

“Using the globally trusted ‘InBody’ scanning device we can determine visceral fats, total body water, protein, bone mineral, body fat mass and more. Pharmacists, in partnership with other healthcare professionals, have an important role in promoting access to health promotion, prevention, screening and early intervention...our pharmacists are committed to providing the best quality programs and services to help customers better manage their health.”

Michelle ChandlerTerry White Chemmart - Hamilton, NSW

"At Clinica Colagrande out team of practitioners offer a diverse range of services that revolve around optimising health and well being. Traditional physical medical examination is considered the bench mark complimented with standard blood tests. Now however, having incorporated the InBody Composition Analysers to the clinic it enables our team of practitioners to accurately quantify over time and assess each patients progress, particularly weight management, musculoskeletal health assessments. We are thrilled with how the InBody Composition Analysers provides us with detailed reports particularly, visceral fat levels, as these are directly correlated to morbidity and mortality outcomes. Clinica Colagrande has embraced the InBody Composition Analyser machine and so has our patients, they love coming back to monitor their progress. Stay healthy, live long and strong with the InBody Composition Analysers!"

Dr Ces ColagrandeMB,BS, BSC,Hons, FEACS

An InBody 770 is now located within the Sleep Disorders Clinic of the RMH. They have identified body composition, particularly Visceral Fat is an important factor for sleep issues and will continue to monitor their patients.

The Royal Melbourne HospitalSleep Disorders Clinic

The Blood Pressure van travels all around New Zealand providing free checks. The Stroke Foundation team have been checking approximately 100 people per day and it on the road 5 days a week.